AzTrials
AzTrials

Postoperative Pain After Cesarean SectionIC-TENS-CSNCT07847502

Interferential Current and Transcutaneous Electrical Nerve Stimulation for Pain After Cesarean Section

A study testing Conventional TENS and Interferential Current Therapy in people with Postoperative Pain After Cesarean Section, run by Dilara Özen Oruk at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to compare the immediate and short-term effects of interferential current therapy and conventional transcutaneous electrical nerve stimulation (TENS) with placebo stimulation on pain and postpartum comfort following cesarean section. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
What is being tested?
Conventional TENS and Interferential Current Therapy
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
54 participants
Where
1 siteTurkey (Türkiye)
Study dates
4 Mar 2026to 1 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women aged 18 to 40 years
  • Ability to read, write, and communicate in Turkish
  • Primiparous women
  • Having delivered a healthy singleton infant by cesarean section
  • No additional surgical procedure or complication during or after the cesarean section

Who cannot join

  • Impaired orientation or cooperation
  • History of systemic disorders, including hyperglycemia or hypertension, gastrointestinal disorders, or urogynecological disorders
  • Previous abdominal surgery
  • Neurological, orthopedic, cardiopulmonary, or other health conditions that may prevent mobilization or ambulation
  • Previous experience with transcutaneous electrical nerve stimulation or interferential current therapy
  • Contraindications to electrical stimulation, including sensory loss at the application site, dermatological problems or allergic reactions at the application site, or a cardiac pacemaker

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dilara Özen Oruk, PhD contact

+902522112072

dilaraozen@mu.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Menteşe State Hospital

    Muğla, 48000

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effects of Interferential Current and Transcutaneous Electrical Nerve Stimulation on Pain Following Cesarean Section

This study aims to compare the immediate and short-term effects of interferential current therapy and conventional transcutaneous electrical nerve stimulation (TENS) with placebo stimulation on pain and postpartum comfort following cesarean section. A total of 54 primiparous women aged 18-40 years will be randomly assigned to an interferential current, TENS, or placebo group. Each intervention will be administered for 30 minutes. Pain intensity at rest and during in-bed activities will be assessed before the intervention, immediately after the intervention, and at 1 and 2 hours after the intervention. Postpartum comfort, treatment satisfaction, anxiety, and depression will also be evaluated.

Read the detailed description

This is a prospective, randomized, placebo-controlled, three-arm clinical trial conducted in the Obstetrics and Gynecology Department of Menteşe State Hospital. The study will include 54 primiparous women following cesarean section. Eligible participants who provide written informed consent will be randomly allocated to the conventional TENS group, interferential current therapy group, or placebo stimulation group.

All interventions will be administered in the supine position with a pillow placed under the knees. Four self-adhesive electrodes will be positioned around the cesarean incision. Conventional TENS will be applied at a frequency of 125 Hz and a pulse duration of 60 microseconds. Interferential current therapy will be applied using a fixed frequency of 100 Hz. In both active intervention groups, current intensity will be increased to a strong but comfortable sensory level and adjusted throughout the session to maintain the same sensation. In the placebo group, the electrodes and device will be applied in the same manner, but no electrical current will be delivered. Each intervention will last 30 minutes.

An assessor blinded to group allocation will perform all evaluations. Pain intensity at rest and during in-bed activities will be assessed using separate 0-10 cm visual analog scales before the intervention, immediately after the intervention, and at 1 and 2 hours after the intervention. Postpartum comfort will be evaluated before the intervention and 2 hours after the intervention using the Postpartum Comfort Questionnaire. Treatment satisfaction will be assessed immediately, 1 hour, and 2 hours after the intervention. Baseline anxiety and depression levels will be evaluated using the Hospital Anxiety and Depression Scale.

Being tested
Conventional TENS, Interferential Current Therapy, Placebo Electrical Stimulation
Keywords
Transcutaneous Electrical Nerve Stimulation, TENS, Interferential Current Therapy, Cesarean Delivery, Postpartum Comfort, Acute Postoperative Pain, Nonpharmacological Pain Management
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional TENSDevice

    Conventional TENS will be applied for 30 minutes at a frequency of 125 Hz and a pulse duration of 60 microseconds. Four self-adhesive electrodes will be positioned around the cesarean incision. Current intensity will be increased to a strong but comfortable sensory level and adjusted during the session to maintain the same sensation.

  • Interferential Current TherapyDevice

    Also called IFC

    Interferential current therapy will be applied for 30 minutes using a fixed frequency of 100 Hz. Four self-adhesive electrodes will be positioned around the cesarean incision in a crossed arrangement. Current intensity will be increased to a strong but comfortable sensory level and adjusted during the session to maintain the same sensation.

  • Placebo Electrical StimulationDevice

    Also called Sham Stimulation

    The electrodes and stimulation device will be applied in the same position and for the same 30-minute duration as in the active intervention groups; however, no electrical current will be delivered.

Study groups in NCT07847502
Study groupRoleWhat they receive
Conventional TENSActive comparatorParticipants will receive one 30-minute session of conventional transcutaneous electrical nerve stimulation following cesarean section.
Receives: Device: Conventional TENS
Interferential Current TherapyExperimentalParticipants will receive one 30-minute session of interferential current therapy following cesarean section.
Receives: Device: Interferential Current Therapy
Placebo StimulationPlacebo comparatorParticipants will receive one 30-minute session of placebo electrical stimulation following cesarean section.
Receives: Device: Placebo Electrical Stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain Intensity at Rest

    Pain intensity at rest will be assessed using a 10-cm Visual Analog Scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity. Changes from baseline will be compared among the three groups.

    Measured: Baseline, immediately after the 30-minute intervention, 1 hour after the intervention, and 2 hours after the intervention

Secondary outcomes (2)
  1. Change in Postpartum Comfort

    Postpartum comfort will be assessed using the Postpartum Comfort Questionnaire. The questionnaire contains 34 items covering physical, psychospiritual, and sociocultural comfort. Total scores range from 34 to 170, with higher scores indicating greater postpartum comfort.

    Measured: Baseline and 2 hours after the intervention

  2. Treatment Satisfaction

    Treatment satisfaction will be assessed using a 10-cm Visual Analog Scale ranging from 0 (not satisfied at all) to 10 (very satisfied). Higher scores indicate greater treatment satisfaction.

    Measured: Immediately after the intervention, 1 hour after the intervention, and 2 hours after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2026
  2. Study start4 Mar 2026
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1:1 ratio to the conventional TENS, interferential current therapy, or placebo stimulation group.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07847502
Sponsor's protocol ID
MSKU-CS-001
Acronym
IC-TENS-CS
Status last verified
Sep 2026
First submitted
22 Sep 2026
Last updated
2 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made publicly available because the dataset contains sensitive obstetric and health information, and public data sharing was not included in the informed consent process.

Questions about this trial

What is this clinical trial studying?

A study testing Conventional TENS and Interferential Current Therapy in people with Postoperative Pain After Cesarean Section, run by Dilara Özen Oruk at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dilara Özen Oruk, PhD (+902522112072, dilaraozen@mu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain Intensity at Rest (time frame: Baseline, immediately after the 30-minute intervention, 1 hour after the intervention, and 2 hours after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in